相关实验视频

Updated: Jun 24, 2025

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

心脏衰竭中的肌肉心脏炎症与减少和保存的射出分数

Pilar Alcaide¹, Marinos Kallikourdis^2,3, Ramona Emig¹

¹Department of Immunology, Tufts University School of Medicine, Boston, MA (P.A., R.E.).

Circulation research

|June 6, 2024

概括

心力衰竭 (HF) 涉及不同的免疫机制,用于减少喷射分数 (EF) 和保存EF类型. 了解这些差异是开发针对心脏病的向治疗的关键.

科学领域:

心脏病学心脏病学
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

心力衰竭 (HF) 是一个主要的全球健康负担,有两种主要的临床类型:心力衰竭的减少喷射率 (HFrEF) 和心力衰竭的保存喷射率 (HFpEF).
尽管有共同的风险因素和心脏重塑特征,但不同的潜在机制区分HFrEF和HFpEF.
目前对HFrEF有效的疗法在HFpEF患者中经常失败,这凸显了需要不同的治疗策略的需要.

研究的目的:

审查和阐明 HFrEF 和 HFpEF 背后的独特免疫机制.
探索HF亚型中的不同免疫特征如何为开发新型治疗点提供信息.
弥合临床前模型和临床数据之间的差距,以全面了解高频.

主要方法:

关于高频率的临床前模型和临床数据的综合文献综述.
在HFrEF和HFpEF中报告的不良心脏重塑机制的分析.
专注于识别和比较免疫系统参与的两种HF类型.

主要成果:

HF亚型表现出独特的免疫系统激活和特征.
特定的免疫路径在HFrEF与HFpEF中对心脏重塑有不同的贡献.
免疫细胞透和炎症媒介在两种HF类型之间存在显著差异.

结论:

独特的免疫机制是HFrEF和HFpEF病原体的核心.
针对特定的免疫路径为不同的HF人群提供了有前途的治疗途径.
进一步的研究整合临床前和临床发现对于个性化HF治疗至关重要.

关键词:

心脏衰竭是因为心脏衰竭.免疫系统免疫系统这是一种炎症炎症炎症炎症.左心室功能,左心室功能腹腔的重塑腹腔的重塑

更多相关视频

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

相关概念视频

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Imbalances in Cardiac Output

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...